The Indian government on Tuesday shared data on the number of people who tested positive for the novel coronavirus after receiving the second dose of Covid-19 vaccines.
According to the data, around 0.04% of people tested positive after the second dose of Covaxin and 0.03% after the second dose of Covishield, the Department of Health said in the press.
India has currently granted emergency use authorization for three candidate vaccines: locally manufactured vaccines (Serum Institute of India and Bharat Biotech) and a third vaccine (Sputnik) which, although currently being manufactured in India foreigner, will eventually be made in India.
Among those under 10 years of age, 4.03 cases of COVID-19 pc were reported in the first wave, while 2.97 pc cases were recorded in the second wave, he added. In the 10-20 year age group, 8.07 pc of COVID-19 cases were reported in the first wave, while 8.50 pc of cases were recorded in the second wave. In the 20-30 age group, 20.41 cases of COVID-19 pc were reported in the first wave, while 19.35 pc cases were recorded in the second wave, while among those aged 30 and over more, 67.5 pc cases of COVID-19 were reported in the first wave, while 69.18 pc cases were recorded in the second wave: Govt, the health ministry said.
Reviewing the Covid-19 situation in the country, Health Secretary Rajesh Bhushan said: “There are 21.57,000 active cases in India currently, double the maximum number of active COVID-19 cases last year. More than 13 million people have been vaccinated in the country to date, including 30 lakh doses given in the past 24 hours. “
On Monday, the Center also announced a “liberalized and accelerated” phase 3 COVID-19 vaccination strategy from May 1 to speed up the coronavirus vaccination campaign in the country.
Anyone over the age of 18 may be eligible for the Covid-19 vaccine, the government said.